Work

Proteomic signatures of acute myeloid leukemia (AML) distinguishes different outcome groups across cytogenetics and identified potential therapy targets

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6523

Authors: R. Tibes, Y. Qiu, K. Coombes, B. Hennessy, H. Kantarjian, F. Giles, E. Estey, G. Mills, S. Kornblau

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2536859416

Cites:

Cited by:

Related to: 10